GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathway.
Ikeuchi H, Matsuno Y, Kusumoto-Matsuo R, Kojima S, Ueno T, Ikegami M, Kitada R, Sumiyoshi-Okuma H, Kojima Y, Yonemori K, Yatabe Y, Takamochi K, Suzuki K, Yoshioka KI, Mano H, Kohsaka S.
Ikeuchi H, et al. Among authors: yoshioka ki.
Oncogene. 2024 Oct;43(41):3037-3048. doi: 10.1038/s41388-024-03105-1. Epub 2024 Aug 3.
Oncogene. 2024.
PMID: 39095584